Skip to content

obesity and risk of diseases

Obesity and non-communicable disease in India: an imaging study of 10,000 adults in the Indian Study of Healthy Ageing (ISHA cohort study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052383
Enrollment
10000
Registered
2023-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Nuffield department of population health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or Female who participated in the previous study (Project No.560) 2. Age: 30-69 (at the time of the enrolment of Project no.560)

Exclusion criteria

Exclusion criteria: 1. Unwilling to participate 2. Has a history of cough, cold, and fever 3. Unable to lie still 4. Unable to hold breath voluntarily or hear instructions 5. Unable to complete the process because of physical disabilities. 6. Pregnant women /lactating women 7. Had surgery in the last 6 weeks 8. Had a scan or x-ray in the last 2 weeks which involved taking a contrast medium

Design outcomes

Primary

MeasureTime frame
1.Describe the detailed anthropometric characteristics in this Indian cohort. 2.Compare conventional measures of adiposity and body fat distribution (derived from weight, height, waist and hip circumference) with DXA-derived measurements in this population. 3.Assess the association between DXA-derived measures of body composition and with cancer and other non- communicable disease risk factors. 4.Enable comparative analyses of the associations between body composition and risk of non- communicable disease (and mediators thereof) in the ISHA cohort and UK Biobank. 5.Undertakethe optical coherence tomography (OCT) imaging to understand association of retinal thickness with cancer and non-communicable disorders. Timepoint: 3 years for enrollment and initial prevalence analysis; further follow up of minimum 10 years Typically longitudinal cohort studies does long-term follow up until all the members of cohort are diseased

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactDr Sharayu Mhatre

Center for Cancer Epidemiology, Tata Memorial Center

mhatresharayu@gmail.com9137792085

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026